key: cord-0710804-gfwc11oy
authors: Barroso‐Arévalo, Sandra; Barneto, Alberto; Ramos, Ángel Manuel; Rivera, Belén; Sánchez, Rocío; Sánchez‐Morales, Lidia; Pérez‐Sancho, Marta; Buendía, Aránzazu; Ferreras, Elisa; Ortiz‐Menéndez, Juan Carlos; Moreno, Inmaculada; Serres, Consuelo; Vela, Carmen; Risalde, María Ángeles; Domínguez, Lucas; Sánchez‐Vizcaíno, José M.
title: Large‐scale study on virological and serological prevalence of SARS‐CoV‐2 in cats and dogs in Spain
date: 2021-11-16
journal: Transbound Emerg Dis
DOI: 10.1111/tbed.14366
sha: f0938be88041af9b6e852859c495e75cd3bb42dc
doc_id: 710804
cord_uid: gfwc11oy

The disease produced by the severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) is currently one of the primary concerns worldwide. Knowing the zoonotic origin of the disease and that several animal species, including dogs and cats, are susceptible to viral infection, it is critical to assess the relevance of pets in this pandemic. Here, we performed a large‐scale study on SARS‐CoV‐2 serological and viral prevalence in cats and dogs in Spain in order to elucidate their role and susceptibility. Samples from animals in contact with COVID‐19 positive people and/or compatible symptoms (n = 492), as well as from random animals (n = 1024), were taken. Despite the large number of animals analyzed, only 12 animals (eight dogs and four cats), which represents 0.79% of the total analyzed animals (n = 1516), were positive for viral SARS‐CoV‐2 RNA detection by reverse transcription quantitative PCR (RT‐qPCR) in which viral isolation was possible in four animals. We detected neutralizing antibodies in 34 animals, four of them were also positive for PCR. This study evidences that pets are susceptible to SARS‐CoV‐2 infection in natural conditions but at a low level, as evidenced by the low percentage of positive animals detected, being infected humans the main source of infection. However, the inclusion of animals in the surveillance of COVID‐19 is still recommended.

& Zarbock, 2020; Voskarides, 2020; Wang et al., 2020) .

These shreds of evidence, together with the fast spread of the virus and its concomitant mortality, have led to considerable concern about the potential capacity of the virus to adapt to other species and become even more transmissible and virulent. Indeed, certain events have confirmed the importance of this concern, such as the detec-tion of new SARS-CoV-2 variants associated with farmed mink in Denmark, including 12 cases with a unique variant ('cluster five variant'), which had a combination of mutations that had not previously been observed (WHO, 2020b) . Although the implications of these changes

are not yet well understood, preliminary outcomes suggested that the mink-associated variant identified in these 12 human cases has moderately decreased sensitivity to neutralizing antibodies (Lassaunière et al., 2020) .

Furthermore, several cases of natural SARS-CoV-2 infection have been identified in animals to date (Delahay et al., 2021) . According to the World Organization for Animal Health (OIE), SARS-CoV-2 RNA has been sporadically detected in dogs, cats, and ferrets (Ferasin et al., 2021; Gortázar et al., 2021; Hamer et al., 2020; Patterson et al., 2020) from many countries, and also in other animals not considered as pets, such as lions, tigers, and pumas (OIE, 2021) . Most of the cases reported have been associated with direct contact between animals and infected humans Ruiz-Arrondo et al., 2020; Sit et al., 2020) . However, natural SARS-CoV-2 infection has also been reported in animals with non-apparent COVID-19 positive contact (Denis et al., 2020; Zhang et al., 2020) or environments in high prevalence settings (Fernández-de-Mera et al., 2020) that are accessible to stray animals. Experimental infection trials have also demonstrated that many animals are susceptible to the infection, particularly in the case of cats (Bosco-Lauth, Hartwig, Porter, Gordy, Nehring, Byas, Woude, et al., 2020; Chen et al., 2020; Shi et al., 2020) , hamsters (Sia et al., 2020) , and ferrets (Kim et al., 2020; Richard et al., 2020; Shi et al., 2020) . Dogs that have undergone experimental inoculation would, however, appear to have a low susceptibility to the virus , although serological studies suggest that they may be infected under natural conditions (Fritz et al., 2020; Y. Zhao, Yang, et al., 2021) .

It is, therefore, essential to study SARS-CoV-2 infection in animals during this pandemic since their potential role as reservoirs or transmitters of SARS-CoV-2 remains unclear. This is particularly important in the case of pets (and principally cats and dogs), which are in direct contact with their owners and are known to be susceptible to the infection (Abdel-Moneim & Abdelwhab, 2020; Hossain et al., 2020; Patterson et al., 2020; Shi et al., 2020) . In this study, we study the prevalence and seroprevalence of SARS-CoV-2 infection in 763 dogs and 753 cats in Spain, which is a high human COVID-19 prevalence country.

In order to reduce the potential for bias, samples were collected from both animals in contact with COVID-19 positive people and/or compatible symptoms, and random animals for which there was no epidemiological evidence that they had come into contact with the disease.

Study enrolment criteria included two kinds of sampling: a selective sampling, which consisted of samples obtained from any pet (cat or dog)

living/in contact with confirmed COVID-19 positive people [household or animal keeper in the case of Animal Protection Centers (APC)]

and/or with clinical signs compatible with the disease (i.e. respiratory

and digestive symptoms, anorexia, and apathy), and a random sampling (which included randomly selected animals that visited veterinary clinics/hospitals or were located in APCs with unknown COVID-19 positive contact and health status However, historical information about stray animals was not available in the majority of the cases. 

SARS-CoV-2-specific RNA was detected using a reverse transcription quantitative PCR (RT-qPCR) assay. Briefly, nasopharyngeal/oropharyngeal/nasal and rectal swabs contained in VTM were extracted under biosafety level 3 conditions at the VISAVET centre at the University Complutense of Madrid, Spain, using the KingFisher Flex System automated extraction instrument (ThermoFisher, Waltham, MA, USA), using the MagMAX Viral/Pathogen Nucleic Acid Isolation Kit (ThermoFisher) according to the manufacturer's instructions.

The detection of SARS-CoV-2 RNA was performed using the envelope protein (E)-encoding gene (Sarbeco) and two targets (IP2 and IP4) of the RNA-dependent RNA polymerase gene (RdRp) in an RT-qPCR protocol established by the World Health Organization according to the guidelines that can be found at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/ technical-guidance/laboratory-guidance (Corman et al., 2020) . Realtime RT-PCR was carried out using the SuperScript III Platinum One-Step RT-qPCR Kit (ThermoFisher) according to the protocol described above in a CFX Connect™ Real-Time PCR Detection System (BioRad, Berkeley, USA). A positive cycle threshold (Ct) cut-off of 40 cycles was used. A result was considered positive when the sample attained a positive result for at least two of the three targets analyzed and was confirmed by the sequencing of the positive PCR product, according to the OIE guidelines (OIE, 2021).

To select an enzyme-linked immunosorbent assay (ELISA) for screening of sera, three commercial ELISA tests were evaluated. First, we Validation of the adapted ELISA was performed by comparing the results of a representing subsample of sera with the results obtained from the previously validated surrogate neutralization assays for SARS CoV-2 (GenScript, Inc., NJ, USA) (Perera et al., 2021) , which was executed according to the manufacturer's instructions. The subsample consisted of 100 sera, which were evaluated by both assays. Cohen's kappa coefficient (κ) was used to calculate the degree of agreement of both tests using SPSS 22 (IBM, Chicago, USA). Sensitivity and specificity for the adapted RBD ELISA test were calculated against the standard surrogate neutralization assays for SARS CoV-2. Sensitivity was calculated as the proportion of test-positive samples over the total number of samples from seropositive animals. Specificity was calculated as the proportion of test-negative samples over the number of seronegative animals. Positive predictive value (PPV; percentage of animals with a positive test which actually have antibodies), and negative predictive value (NPV; percentage of animals with a negative test which do not have antibodies) were calculated according to Parikh et al. (2008) .

All doubtful or positive serum samples were evaluated by employing the virus neutralization test (VNT) to confirm the existence of neutralizing antibodies.

Virus neutralization test 

Specimens that tested positive for qRT-PCR were subjected to virus isolation in Vero E6 cells. These cells were cultured in RPMI supplemented with 10% FBS, 100 IU/ml penicillin, and 100 μg/ml streptomycin (growth medium). The cells were then seeded in 96-well culture plates and cultured at 37 • C with 5% CO 2 for 2448 h, after which they were inoculated with 10 μl of the direct sample contained in VTM (oronasal or rectal swabs). Mock-inoculated cells were used as negative controls. The cultured cells were maintained at 37 • C with 5% CO 2 , with a daily observation of CPE and cellular death. After 6 days, the cell cultures were frozen, thawed, and subjected to three passages with inoculations of fresh Vero E6 cell cultures with the lysates, as described above. SARS-CoV-2 molecular detection was performed by employing RT-qPCR on the supernatants from every passage in order to confirm the presence/absence of the virus in the cell culture and virus recovery by means of the decrease in the Ct.

Whole-genome sequencing was performed on the samples with Ct values under 30 or the isolates from those samples in which viral isolation was possible. In the remainder of positive samples, attempts to sequence the spike protein genome were made as described in Barroso-Arévalo et al. (2021) .

Whole-genome sequences from five positive samples from cats and dogs were obtained by RT-PCR with 38 primers sets following the protocol described by Paden et al. (2020) . Sequence analysis was performed using the Sequencing Analysis software v.5.3.1 (Applied Biosystems), while SeqScape v.2.5 software (Applied Biosystems) was used for sequence assembly using the SARS-CoV-2 isolate Wuhan-Hu-1, complete genome (GenBank accession number: NC_045512) as a ref-

Phylogenetic analysis was performed using MEGA X software (Tamura, 1992) . A total of 54 representative sequences were used for the analysis, including sequences from cats and dogs, the reference genome from Wuhan, as well as variants of concern such as the B. The final alignment included 59 sequences and was considered adequate because it was associated with an average amino acid p-distance (1-amino acid identity) of 0.014. This value is within the acceptance threshold of <0.8 (Tamura, 1992) . From this alignment, the phylogenetic tree was constructed using the maximum likelihood method and Subtree-Pruning-Regrafting algorithm and bootstrap testing of 2000 replicates.

Mutations were determined using the CoVsurver mutations app available on the GISAID website (https://www.gisaid.org/). We gratefully acknowledge the various laboratories and contributors of GISAID for providing these SARS-CoV-2 sequences.

A total of 763 dogs and 753 cats were sampled (total n = 1516 animals), representing 3670 samples. Table 2 shows the distribution of the animals based on the type of sample (selective or random) in each

Autonomous Community. Figure 1 shows the percentage of the total number of animals (dogs and cats) in each Autonomous Community.

In the selective sampling, 85.16% of the animals had a COVID- 

SARS-CoV-2 RNA was detected by means of RT-qPCR and sequencing in eight dogs and four cats. Table 3 shows the PCR positive animals and their distribution depending on the type of sampling, as well as the percentage that these animals represent in each sampling.

These 12 animals met the OIE criteria of the animal case definition for SARS-CoV-2 with regard to positive respiratory and/or rectal swabs (Tables 4 and 5 ). Two of the positive dogs also tested positive for RNA detection in the case of samples obtained from their surfaces using environmental sponges (Table 4) . All the animals that tested positive for RT-qPCR were re-tested as soon as possible after the positive result had been obtained. One dog (D+-7), which resulted positive with a high viral load based on PCR results, was positive again when it was resampled 3 days after the original sampling. This dog was negative when re-tested 19 days after the initial sampling. One cat (C+-1) attained a positive result for the nasopharyngeal swab collected 14 days after the initial PCR (Table 5) .

Attempts were made to isolate the virus from all the RT-qPCR positive swabs. SARS-CoV-2 was isolated from four animals: from the rectal swab of one dog (+D-3), for which CPE was observed in the second and third passages, and virus recovery was confirmed by means of PCR (Ct value reduction from cell suspension of first passage to second and third passages); from the nasopharyngeal swab of one cat (+C-1), for which CPE was observed in the second and third passages and virus recovery was confirmed by means of PCR; from the nasopharyngeal swab of another cat (+C-2), for which no CPE was noted on day 7 but virus recovery was confirmed by means of PCR;

and from the nasal and rectal swab of another dog (+D-7), with CPE noted in all passages, in which virus recovery was confirmed by means of PCR. Detailed description about samples in which viral isolation was possible is presented in Supporting Information 1 and 2.

Validation of adapted RBD ELISA was performed using a subsample of 100 sera (Table 6 ). Before evaluation with the adapted RBD ELISA, these sera were also analyzed using the previously validated surrogate neutralization assay for SARS CoV-2 described above. Based on this comparative assay, sensitivity and specificity were 93% and 95%, respectively. Both tests had a kappa agreement of 0.827. 

A total of 1488 sera were evaluated using the screening RBD ELISA.

Of these sera, 59 showed a positive or doubtful result and were subsequently evaluated by VNT.

A total of 20 dogs (Table 7) , 16 of these from the selective sampling and four from the random sampling, had neutralizing antibodies, with titres ranging from 1/16 to 1/128. Four of these dogs were also positive for RT-qPCR (+D-1, +D-3, +D-7, and +D-8, Tables 4 and 7) and had neutralizing antibodies 14, 10, and 19 days after testing positive for PCR and the same day as the positive PCR, respectively. Two of the other VNT positive dogs from the selective sampling (VNT D-1 and VNT D-2) were living with the PCR-positive dogs mentioned above (+D-1 and +D-3, respectively). Other 10 VNT-positive dogs had also been in contact with COVID-19 positive people, and only one of these had respiratory signs (cough and dyspnea). The other four VNTpositive dogs belonged to the random sampling, so they did not have any apparent COVID-19 positive contact nor compatible symptoms.

On the other hand, 14 cats had neutralizing antibodies ( Table 7) .

One of these cats was positive for RT-qPCR and had neutralizing antibodies in the serum collected at the same time as the positive PCR (+C-2) (titter 1/32) (Table 3) . Another PCR-positive cat (+C-4) also had neutralizing antibodies, with a titre of 1/64 obtained on the same day as the positive PCR and 1/32 15 days after the positive PCR. Other 11 VNT-positive cats (which were negative for PCR) were included in the selective sampling as they lived with a COVID-19 positive owner and/or had compatible symptoms (Table 6 ). Only one VNT-positive cat belonged to the random sampling (VNT C-12) and was a stray cat.

We employed special sponges with a surfactant liquid that allows for viral inactivation in order to assess the presence of environmental viral RNA in animal surfaces. In addition to +D-5 and +D-7 (Table 4) positive owners, although nasal and rectal swabs, along with the blood from these dogs, tested negative in both cases. However, one of these dogs was positive for VNT (VTN-D-8, see Table 7 ). All the environmental samples showed Ct values above 30 except for the second sample taken from the hair and skin of +D-7 (average Ct: 25.56).

Five complete genome sequences were obtained from the nasal swab of +D-1, the rectal swab of +D-3 (viral culture isolate), the nasal swab of +D-7, and the oropharyngeal swabs of +C-1 and +C-2 (viral culture isolates). GenBank accession numbers are shown in Table 8 .

Evolutionary relationships among the whole genomes were inferred using maximum likelihood based on the general time-reversible model (Tamura, 1992) . The analysis involved 59 nucleotide sequences, including first, second, third, and non-coding codon positions. All positions with less than 95% site coverage were eliminated. That is, fewer than 5% alignment gaps, missing data, and ambiguous bases were allowed at any position. In the end, 29,514 positions were analyzed. The bootstrap consensus tree inferred from 2000 replicates (Kumar et al., 2018) was taken to represent the evolutionary history of the taxa analyzed.

Branches were collapsed if the corresponding partitions occurred in fewer than 50% of bootstrap replicates. Initial tree(s) for the heuristic search were obtained automatically by applying neighbour-joining and BioNJ algorithms to a matrix of pairwise distances estimated using maximum composite likelihood and then selecting the topology with a better log-likelihood value. Differences in the rate of evolution among different sites were modelled using a discrete gamma distribution (two categories, +G parameter = 0.059).

Phylogenetic analysis showed that sequences from +C-1 and +C-2

were very similar and clustered with the genome from +D-3. Sequence from +D-1 was also close to the sequences cited above (Figure 2) , and the four sequences were also close to the reference genome from

Wuhan. On the other hand, sequence from +D-7 was identified as the variant of concern B.1.1.7, clustering with sequences of this variant Mutation analysis on the CoVsurver mutations app detected several mutations in the sequences obtained (Table 8) .

This is, to our knowledge, the first large-scale study on serological, epidemiological, and virological identification, including viral isolation of SARS-CoV-2 in cats and dogs from different regions of Spain. Our results confirm that pets (dogs and cats) can be infected by SARS-CoV-2 and are even able to develop neutralizing antibodies against the virus, as other authors have found (Dias et al., 2021; Hamer et al., 2020; Patterson et al., 2020; Ruiz-Arrondo et al., 2020) . Here, we have also iso- At present, there is no evidence of SARS-CoV-2 transmission from pets to humans, although this has been confirmed in the case of minks (Hammer et al., 2021) , with a large number of outbreaks reported (OIE, 2021) , showing that mink farms could represent a serious, unrecognized animal reservoir for SARS-CoV-2 (Hammer et al., 2021) . Mink-tohuman transmission has also been demonstrated (Oude Munnink et al., 2021) and was associated with the development of a new mink-related variant (WHO, 2020b). On the contrary, none of these phenomena have as yet been described in pets. However, transmission between cats via respiratory droplets has been demonstrated (Halfmann et al., 2020; Shi et al., 2020) , although the serial passaging of the virus between cats naturally attenuated the viral transmissibility, as has been reported by Bao et al. (2021) . In the case of dogs, data from experimental studies suggest that they can also become infected, but might not spread the virus to other dogs as easily as occurs with cats Shi et al., 2020; Sit et al., 2020) . However, and with the knowledge we have attained to date, the possibility of pet-to-pet and pet-to-human spread cannot be completely ruled out. Great caution is, thus, necessary with regard to this topic, and the scientific community must continue to study this potential transmission route.

We found a low prevalence of infected pets on the basis of RNA viral detection, which coincides with the results obtained in other stud-F I G U R E 2 Maximum likelihood phylogeny was estimated with n = 59 complete genomes sequences from the current (2019−2021) SARS-CoV-2 retrieved from GISAID. Open square indicates references from this study; open circle indicates the reference genome from Wuhan. Number along branch represents bootstrap score. Scale bar represents expected substitutions per nucleotide site ies (Hamer et al., 2020; Patterson et al., 2020; Ruiz-Arrondo et al., 2020) . However, the possibility that a larger number of animals could have been infected cannot be discarded despite the negative results obtained using PCR. The features of our sampling signified that there was a critical delay between the COVID-19 positive contact and the moment at which the veterinarian was able to perform the sampling.

Restriction measures and quarantine force owners to stay at home, and they cannot, therefore, go to the veterinary hospital/clinic to get their pet sampled. It is thus possible that more animals were infected, but as the period in which cats and dogs shed SARS-CoV-2 may be very short, along with the fact that they may have undergone asymptomatic infection, we were unable to pinpoint the moment of acute infection.

One proof of this is that we detected neutralizing antibodies in several animals that tested negative when employing PCR (16 out of 20 VNTpositive dogs were negative for PCR, and 12 out of 14 VNT-positive cats were negative for PCR), which shows that these animals had an active infection at some point. In future work, it would be advisable to perform a more active sampling, as has occurred in other studies, in order to find active virus infection (Hamer et al., 2020; Temmam et al., 2020) , as well as to perform experimental infection assays. The low viral loads found in this study may also be explained by the delay between the positive contact and the pet sampling. For instance, +D- As expected, most of the positive cases to PCR were included in the selective sampling and had contact with COVID-19 positive people (11/12). The same occurred in the case of animals that tested positive for neutralizing antibody detection. In fact, two of the VNT-positive dogs were living with two other animals (also dogs) that tested positive for PCR, respectively. In these particular cases, we were unable to elucidate whether a pet-to-pet transmission had occurred or whether the positive human contacts were the source of the infection for these animals. According to the experimental studies carried out to date, human-to-pet transmission would appear to be the most likely pathway, since dog-to-dog transmission has not yet been demonstrated . The fact that more dogs were positive for both PCR and VNT despite their lower susceptibility may be explained by the species behaviour. Dogs usually come into closer contact with their owners than cats, thus facilitating viral transmission through kisses, licks, and other kinds of contact.

Interestingly, one cat (C+−1) belonging to the random sampling tested positive for PCR with regard to both oropharyngeal and rectal swabs. We were able to isolate the virus from the oropharyngeal sample obtained from this animal, which demonstrated that an active infection was occurring. Apparently, the owners of this cat did not have any symptoms compatible with COVID-19 disease and had not been subjected to a PCR test, but we suspect that they may have been asymptomatic. These results highlight that animals can get infected even in supposedly virus-free environments. In this context, it is possible to assume that the cat could have been exposed to the virus at any time. Although the cat had a history of digestive problems (diarrhoea secondary to chronic intestinal inflammation), these symptoms did not appear to have been triggered by SARS-CoV-2 infection since they were previous to the sampling time. Besides, it was possible to isolate the virus from its oropharyngeal swab, which indicated that the cat was suffering from an active infection. Another fact that supports this hypothesis is that the oropharyngeal swab was again positive when the cat was re-tested 14 days after the initial positive PCR, suggesting a persistent but asymptomatic infection. This cat, however, did not have any neutralizing or non-neutralizing antibodies when its sera were tested using VNT and the RBD ELISA, respectively.

It was also possible to isolate the virus from the nasopharyngeal swab of another cat (C+−2), from the rectal swab of one dog (D+−3), and from the nasal and rectal swabs from another dog (D+−7 is not infectious anymore. In our study, we have detected SARS-CoV-2 RNA in the surface (hair and skin) of seven animals. Two of them (+D-5 and +D-7) were also positive for rectal and/or nasal swabs, respectively. As both animals were living with COVID-19 positive owners, we could not elucidate if the animal shedding was the source of the environmental RNA. The other five cases of environmental detection were detected in animals from the selective sampling, living with COVID-19 positive owners, but negative for PCR and neutralizing antibody detection, except for one dog, which was positive for VNT (VTN-D-8, see Table 7 ). Therefore, this dog was previously exposed to the virus, was infected, and recovered from the infection, developing neutralizing antibodies. Although the environmental RNA viral loads detected in most of the cases were low (Cts above 30), we cannot discard the role of these animals as potential carriers of the virus on their surfaces. Hence, this methodology may be a good approach for the detection of environmental RNA and exposure to SARS-CoV-2 in pets.

On the other hand, it is also important to note that N proteinbased ELISA tests showed specificity problems, as reported before (Zhao, Schuurman et al., 2021) . This fact may be a consequence of a cross-reaction between some other coronaviruses which infect animals without triggering any clinical disease. It is known that several viruses from Coronaviridae family can infect animals (in this case, cats and dogs) (Haake et al., 2020) . Notable coronaviruses of companion animals include feline enteric coronavirus (FCoV), feline infectious peritonitis virus, and canine enteric coronavirus (CCoV). It has been previously demonstrated that antigenic cross-reactivity between SARS-CoV-2 and FCoV type N proteins exists (S. Zhao, Schuurman, et al., 2021) . Taken into account the endemic nature of FCoV infection in cats, some of the false positive detected in cat sera may be consequence of cross-reaction with this infection. However, as described above, no cross-reaction was detected for both N-based ELISA tests with the specific-species coronavirus in our case since several false positive sera were negative for FCoV and CCoV ELISA tests in cats and dogs, respectively. Therefore, we suspect that other coronavirus

not identified yet may also be involved in the non-specific outcomes results obtained with the N protein. Based on these outcomes, the N protein does not appear to be a good target for anti-SARS-CoV-2 antibody detection in cats and dogs.

Regarding seroprevalence, we found neutralizing antibodies in a total of 34 animals (20 dogs and 14 cats) using VNT. Five of these animals were included in the random sampling (four dogs and one cat), so they did not have any apparent contact with COVID-19 positive people. The four dogs were owned pets, while the cat was a stray animal. These outcomes evidence that these animals were exposed to the virus at some time, probably by environmental contamination or asymptomatic owners in the case of pets, suffered from asymptomatic infection, and developed an immune response based on neutralizing antibodies. Seroprevalence in stray animals has been previously reported by others authors in Wuhan, China (Y. Zhao, Yang, et al., 2021) ; and Rio de Janeiro, Brazil (Dias et al., 2021) . All of this demonstrates that human-to-animal transmission events are not only restricted to domestic animals and therefore highlight the importance of performing surveillance in this kind of animals.

All these results evidence that cats and dogs in close contact with people who are positive for the virus may develop a SARS-CoV-2 infection, but also when they are not apparently exposed to the virus, as our seroprevalence results showed. However, our findings are encouraging, since only a low percentage of the animals sampled attained a positive result for PCR and/or neutralizing antibody detection, indicating that infection in pets would appear to be anecdotic. Nevertheless, it is still advisable to continue monitoring COVID-19 status in pets, given the zoonotic origin and the particular and not fully known characteristics of the virus. The South Korean Government recently announced that it will test any pet that has been in contact with a COVID-19 person and/or has had any symptoms that are compatible with the disease. In the case of a positive result, the pet must be quarantined for 14

days. Other countries are performing similar studies on pets. Although there is no regulation in this respect in Spain, more tests should be conducted on pets, especially those living with positive families. Preventive measures should be taken by owners who are COVID-19 positive (i.e.

they should avoid kissing their pets and decrease unnecessary contact).

By simply implementing these measures, SARS-CoV-2 infected people could decrease the risk of their pets becoming infected.

We want to thank all the pet owners and veterinarians who partic- 

Evidence for SARS-CoV-2 infection of animal hosts

Evidence for camel-to-human transmission of MERS coronavirus

Susceptibility and attenuated transmissibility of SARS-CoV-2 in domestic cats

First detection of SARS-CoV-2 B.1.1.7 variant of concern in an asymptomatic dog in Spain

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats

transmission and response to re-exposure of SARS-CoV-2 in domestic cats

Single-cell screening of SARS-CoV-2 target cells in pets, livestock, poultry and wildlife

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Assessing the risks of SARS-CoV-2 in wildlife

COVIPENDIUM: Information available to support the development of medical countermeasures and interventions against COVID-19

Neutralizing antibodies for SARS-CoV-2 in stray animals from Rio de Janeiro, Brazil

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Myocarditis in naturally infected pets with the British variant of COVID-19

Detection of environmental SARS-CoV-2 RNA in a high prevalence setting in Spain

High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households

Natural SARS-CoV-2 infection in kept ferrets

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

Coronavirus infections in companion animals: Virology, epidemiology, clinical and pathologic features

Transmission of SARS-CoV-2 in domestic cats

Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in

SARS-CoV-2 transmission between mink (Neovison vison) and humans

Animals and SARS-CoV-2: Species susceptibility and viral transmission in experimental and natural conditions, and the potential implications for community transmission. Transboundary and Emerging Diseases

SARS-CoV-2 host diversity: An update of natural infections and experimental evidence

Infection and rapid transmission of SARS-CoV-2 in ferrets

MEGA X: Molecular evolutionary genetics analysis across computing platforms

Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data

Possible bat origin of severe acute respiratory syndrome coronavirus 2

Risk factors associated with COVID-19 infection: A retrospective cohort study based on contacts tracing. Emerging Microbes & Infections

Coronaviruses and SARS-CoV-2: A brief overview

Environmental DNA: A promising factor for tuberculosis risk assessment in multi-host settings

COVID-19 portal, events in animals

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Rapid, sensitive, full-genome sequencing of severe acute respiratory syndrome coronavirus 2

Understanding and using sensitivity, specificity and predictive values

Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy

Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. The Lancet Infectious Diseases

SARS-CoV-2 is transmitted via contact and via the air between ferrets

Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Infection of dogs with SARS-CoV-2

Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases

Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

Animal-to-human viral transitions: Is SARS-CoV-2 an evolutionarily successful one

The genetic sequence, origin, and diagnosis of SARS-CoV-2

SARS-CoV-2 mink-associated variant strain -Denmark

Zoonotic origins of human coronavirus 2019 (HCoV-19 /SARS-CoV-2): Why is this work important?

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation

Serologic screening of severe acute respiratory syndrome coronavirus 2 infection in cats and dogs during first coronavirus disease wave, the Netherlands

A serological survey of severe acute respiratory syndrome coronavirus 2 in in uhan

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Large-scale study on virological and serological prevalence of SARS-CoV-2 in cats and dogs in Spain